GFL Ltd

- There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript. - The company discusses ongoing investments and CAPEX, particularly Rs 100 to Rs 125 crores planned for FY18 for capacity enhancements and debottling. - They have already secured lender consent for a transaction involving 23 MW capacity assets, expecting closure within 3-4 months. - Standalone net debt is around Rs 220 crores, with no indication of raising additional debt. - The focus appears to be on growing specialty fluoropolymers and chemical intermediates through internal accruals and minor CAPEX rather than fresh fundraising. In summary, no direct plans or announcements regarding new debt or equity fundraising were disclosed during this call.

- Rs 50-75 crore invested over the last 12 months in specialty fluoropolymers including micro powders, PFA, FEP, PVDF, and FKM. - No further major investment needed in specialty fluoropolymers; focus is on commercializing developed products over 12-15 months. - For FY 2017-18, capex of about Rs 100-125 crore planned for debottlenecking and enhancing TFE capacity and adding some PTFE capacity. - Minor capex possible to double capacities in 2-3 specialty fluoropolymer products with low investment. - Investments of Rs 125-150 crore planned in fluorospecialty intermediate business (pharma and agri sectors), with plants commissioning by September end (FY17). - Seeking regulatory approvals and lender consents for unlocking 23 MW wind farming assets within 3-4 months.

- Speciality fluoropolymers: Full utilization expected in 10-15 months with revenues of Rs 400-500 crores annually at full capacity. - Specialty fluoropolymer investments of Rs 50-75 crores made over the last 12 months; additional capacity can be doubled with minor CAPEX. - PTFE volumes strong; current quarter near 100% capacity utilization with plans for debottlenecking to increase capacity. - Refrigerants: New plant for R125 in setup, expected to increase TFE demand and PTFE sales in 2-3 quarters. - Fluorospeciality intermediate business (pharma & agri) expected to generate revenues starting Q2 FY18. - Micro powders, PFA, FEP: About 30% existing customers; PVDF and FKM involve new customers, mainly automotive sector. - Overall, strong focus on exports (~75% to US/Europe) with progressive volume growth as products improve and marketing expands.

- Speciality fluoropolymers business expected to reach full capacity utilization in 10-15 months, with revenues of Rs 400-500 crores annually at full capacity. - Investment in speciality fluoropolymers was Rs 50-75 crores over last 12 months; capable of doubling capacity with minor CAPEX. - PTFE volumes and prices improving, driving strong growth and profitability. - Export markets (US and Europe) targeted for 75% of speciality fluoropolymer sales, implying growth from international demand. - Fluorospeciality intermediates for pharma and agri sectors expected to generate revenues starting Q2 FY18 with investments of Rs 125-150 crores in progress. - Overall chemical business PAT increased 53% for full year FY17, suggesting strong earnings momentum. - Management anticipates steady volume and margin improvements in speciality chemicals and fluoropolymers over next 12-15 months, supporting growth in operating profits and EPS.

- The transcript does not explicitly disclose specific details about the current or expected order book or pending orders for Gujarat Fluorochemicals Limited. - However, it mentions ongoing developments such as: - Specialty fluoropolymers expected to reach full utilization in 10 to 15 months, indicating growing demand and scaling prospects. - Active market scanning and established contacts for new and existing fluoropolymer products including micro powders, PFA, FEP, PVDF, and FKM targeted mainly at automotive and international markets. - The company is preparing for commercialization of developed specialty products over the next 12-15 months, implying expected order inflows. - Discussions about capacity expansion (doubling capacity in 2-3 products with minor CAPEX) suggest readiness for increased orders. - No quantitative figures or explicit order backlog values are provided in the transcript.